Crowdonomics
This isn’t BioLife4D Corp’s most recent raise. Rule 506(b) · Convertible Note · Jan 2019 (Closed) is more current.View latest round
BioLife4D Corp

Reg A+ · Equity · Dec 2017

ClosedReg A+Equity
via the platform · last checked Sep 24, 2026
Raised
$4M / $50M max
8% of ceiling
Investors
—
—
Valuation
—
—

Financials disclosed in this offering

No financial statements linked to this round

The issuer's filing for this offering hasn't been parsed into fiscal-year statements yet.

Amendments to this offering

10 amendments
  1. Oct 21, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  2. Oct 16, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  3. Oct 13, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  4. Jul 20, 2020
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  5. Aug 12, 2019
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  6. Jul 26, 2019
    Terms not yet extracted from this filing
    Form 1-A POS on EDGAR ↗
  7. Jan 22, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  8. Jan 8, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  9. Jan 3, 2018
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  10. Dec 22, 2017
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Price / share$10.00
Shares offered500,000

Offering details

Target—
Max$50,000,000
Min investment—
OpenedDec 21, 2017
Deadline—
ClosedDec 22, 2021
Days active1,462

Links & provenance

Source: SEC EDGAR
0001477932-17-006192
Last synced Sep 24, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.